Cancer rates continue to skyrocket, and the overall survival rate for Stage IV cancer patients in the United States is a grim 2.1 percent. Clearly, the extensive use of expensive, sometimes ineffective toxins in conventional oncology protocols is a failing strategy. Even the few survivors of these harsh slash-and-burn treatments can have dismal quality of life, suffering with ailments such as nerve damage, heart muscle disease, and liver and kidney failure. And unfortunately, many conventional doctors discourage patients from exploring alternative treatment options.

A featured doctor in...